Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Pediatr Infect Dis J. 2017 Sep;36(9):855–859. doi: 10.1097/INF.0000000000001610

Table 3.

Adjusted odds ratio (95% confidence intervals) for adverse events comparing the third vs. the first tertiles for piperacillin steady-state area under the concentration vs. time curve from zero to tau (AUCss,0-τ) and steady-state maximal concentration (Cmaxss) controlling for gestational age.

Clinical and Laboratory AEs* Adjusted Odds Ratio (95% CI) for Third vs. First Tertiles of AUCss,0-τ (mg*hr/L) Adjusted Odds Ratio (95% CI) for Third vs. First Tertiles of Cmaxss (mg/L)
Seizures 3.63 (0.73, 18.0) 0.75 (0.07, 8.55)
Rash 1.02 (0.14, 7.22) 0.75 (0.12, 4.90)
Hypernatremia 1.24 (0.40, 3.89) 1.01 (0.27, 3.79)
Hypokalemia 0.64 (0.28, 1.42) 0.87 (0.39, 1.98)
Elevated creatinine 0.74 (0.17, 3.20) 0.55 (0.11, 2.81)
Thrombocytopenia 1.24 (0.84, 1.83) 1.10 (0.74, 1.65)
Leukopenia 0.87 (0.51, 1.49) 0.81 (0.46, 1.42)
Low hematocrit 1.11 (0.75, 1.65) 1.14 (0.76, 1.70)
Prolonged PT 0.29 (0.06, 1.43) 0.68 (0.21, 2.18)
Prolonged PTT 0.22 (0.02, 1.90) 0.51 (0.09, 2.92)
Elevated AST 0.37 (0.04, 3.68) 0.24 (0.03, 2.23)
Elevated ALT 0.66 (0.09, 4.94) 0.30 (0.03, 3.35)

Adverse events, AEs; confidence intervals, CI; PT, prothrombin time; PTT, partial thromboplastin time; AST, aspartate aminotransferase; ALT, alanine transaminase

*

Please refer to Table 1 for the criteria used to determine laboratory AEs and SAEs